Open AccessCoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
Author(s) -
Wannada Laisuan,
Chamard Wongsa,
Chirawat Chiewchalermsri,
Torpong Thongngarm,
Ticha Rerkpattanapipat,
Pansa Iamrahong,
Chulapha Ruangwattanachok,
Sira Nanthapisal,
Mongkhon Sompornrattanaphan
Publication year - 2021
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s333098
Subject(s) - medicine , anaphylaxis , covid-19 , allergy , drug allergy , immunology , dermatology , virology , disease , infectious disease (medical specialty)
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.